Code : 9822-358315      Created Date : Wednesday, January 4, 2023   Visit : 319

The report of 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis 27th Annual RIMS Conference by Mohammadreza Fattahi

The report of 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis 27th Annual RIMS Conference by Mohammadreza Fattahi

 Application Code :

846-0222-0020
 
Created Date : Tuesday, October 18, 2022-14:52 14:52:27Update Date : Saturday, November 5, 2022-20:07 20:07:13
IP Address : 194.225.53.59Submit Date : Saturday, November 5, 2022-20:07 20:07:35Email : mrfatahi93@gmail.com
International Congress Form(for Students and Staff)
Personal Information

 

Name: : Mohammad Reza
Surname: : Fattahi
Position: : student
School/Research Center: : Sina Hospital
Department : MS Research Center, Neuroscience Institute
Student Card/Staff Contract: : http://gsia.tums.ac.ir/images/UserFiles/77720/Forms/846/گواهی_اشتغال_به_تحصیل_research_diploma.pdf
The Abstract that you e-mailed to the Congress Secretary: : http://gsia.tums.ac.ir/images/UserFiles/77720/Forms/846/Abstract_1032-2-2.pdf
The Acceptance that is e-mailed from the Congress Secretary: : http://gsia.tums.ac.ir/images/UserFiles/77720/Forms/846/Gmail_-_ECTRIMS_2022_-_Abstract_Notification.pdf
The presentation: : eposter
Title of the Congress: : 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis 27th Annual RIMS Conference
Title of your Abstract: : Infections in patients with Multiple Sclerosis treating with Disease-Modifying Therapies: a risk assessment cohort study
Destination Country: : Netherlands
From: : Wednesday, October 26, 2022
To: : Friday, October 28, 2022
Please give a briefing of your own observations and outcomes of the congress: : We have presented our prospective cohort study and get the international professionals idea in order to improve our research method for future investigations in MS Research Center under the supervision of Professor Sahraian.
Your Comments :
captcha
Close